Roth Keeps ImmunoCellular (IMUC) at Neutral; Sidelined Until ICT-107 Picture Clears

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. SPY
4. JPM
5. ICLR
6. USO
7. LAES
8. FUL
9. IBM
10. TSHA

Go back to Roth Keeps ImmunoCellular (IMUC) at Neutral; Sidelined Until ICT-107 Picture Clears

Immunocellular Therapeutics, Ltd. (IMUC) Posts Break Even Q4 Loss

March 13, 2014 4:14 PM EDT

Immunocellular Therapeutics, Ltd. (NYSE: IMUC) reported Q4 EPS of $0.00, $0.09 better than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Immunocellular Therapeutics, Ltd. (IMUC) click here.... More